Multi-stakeholder perspectives highlight benefits and challenges in EU-level clinical assessment harmonization.
The process of harmonization induced by the HTAR is beneficial to standardize clinical assessment at the EU level, but needs to reconcile different stakeholder perspectives.
No takes yet. Share an insight, caveat, or question.
Meregaglia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: